Lina Ba
Impact in
- Cancer Research top 10%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Sensory Systems top 10%
- Ion Channels and Receptors
Papers in
-
- RNA modifications and cancer 5
- Circular RNAs in diseases 3
- RNA Research and Splicing 3
-
- Cancer-related molecular mechanisms research 6
- MicroRNA in disease regulation 3
- Co-authors
- Yonggang Cao (13 shared papers)Pilong Shi (6 shared papers)Hanping Qi (15 shared papers)Junwei Yan (2 shared papers)Hongli Sun (9 shared papers)Yunping Chen (5 shared papers)Xiaolei Li (1 shared paper)Xuejiao Yang (1 shared paper)
- Journals
- European Journal of Pharmacology (4 papers)Phytomedicine (2 papers)Molecular Therapy — Nucleic Acids (2 papers)Cell Death Discovery (2 papers)Journal of Cellular and Molecular Medicine (2 papers)
- Partner nations
- ChinaNetherlands
In The Last Decade
Lina Ba
21 papers receiving 806 citations
Peers
Comparison fields: 5 of 83
- Cancer Research 222
- Sensory Systems 45
- Pharmacology 56
- Pulmonary and Respiratory Medicine 174
- Molecular Biology 402
Countries citing papers authored by Lina Ba
This map shows the geographic impact of Lina Ba's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lina Ba with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lina Ba more than expected).
Fields of papers citing papers by Lina Ba
This network shows the impact of papers produced by Lina Ba. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lina Ba. The network helps show where Lina Ba may publish in the future.
Co-authors
The 25 scholars most cited alongside Lina Ba, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 23 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 202 | |
| 2 | 2018 | 149 | |
| 3 | 2016 | 77 | |
| 4 | 2019 | 44 | |
| 5 | 2021 | 44 | |
| 6 | 2013 | 41 | |
| 7 | 2018 | 30 | |
| 8 | 2017 | 29 | |
| 9 | 2018 | 29 | |
| 10 | 2019 | 27 | |
| 11 | 2017 | 25 | |
| 12 | 2022 | 21 | |
| 13 | 2023 | 18 | |
| 14 | 2021 | 16 | |
| 15 | 2016 | 14 | |
| 16 | 2013 | 13 | |
| 17 | 2021 | 12 | |
| 18 | 2021 | 7 | |
| 19 | 2024 | 7 | |
| 20 | 2023 | 6 |
About Lina Ba
Lina Ba is a scholar working on Molecular Biology, Cancer Research, Pharmacology, Sensory Systems and Cardiology and Cardiovascular Medicine, having authored 23 papers that have together received 813 indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (6 papers), RNA modifications and cancer (5 papers), Circular RNAs in diseases (3 papers), RNA Research and Splicing (3 papers), Pharmacogenetics and Drug Metabolism (3 papers), MicroRNA in disease regulation (3 papers), Ion Channels and Receptors (3 papers) and Ferroptosis and cancer prognosis (2 papers). The work is most often cited by research in Cancer Research (222 citations), Sensory Systems (45 citations), Pharmacology (56 citations), Pulmonary and Respiratory Medicine (174 citations) and Molecular Biology (402 citations). Lina Ba has collaborated with scholars based in China and Netherlands. Frequent co-authors include Yonggang Cao, Pilong Shi, Hanping Qi, Junwei Yan, Hongli Sun, Yunping Chen, Xiaolei Li, Xuejiao Yang, Jingquan Gao and Qianhui Zhang. Their work appears in journals such as European Journal of Pharmacology, Phytomedicine, Molecular Therapy — Nucleic Acids, Cell Death Discovery and Journal of Cellular and Molecular Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.